Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Examining international practices in the management of pregnant women with von Willebrand disease

Lavin, M., Sánchez Luceros, A., Kouides, P., Abdul‐Kadir, R., O’Donnell, J.S., Baker, R.I., Othman, M. and Haberichter, S.L. (2021) Examining international practices in the management of pregnant women with von Willebrand disease. Journal of Thrombosis and Haemostasis . Early View.

[img]
Preview
Free to read: https://doi.org/10.1111/jth.15561
*No subscription required

Abstract

Background

The management of pregnant women with von Willebrand disease (VWD) is complex as physiological pregnancy-induced increases in plasma von Willebrand factor (VWF) may be blunted or absent. Women with VWD experience a heightened risk of postpartum hemorrhage (PPH) and special consideration must be given regarding neuraxial anesthesia (NA) and the need for prophylaxis at time of delivery. These challenges are compounded by a lack of robust evidence to guide clinical decision-making.
Objectives and Methods

To determine the current international clinical practices in the management of pregnancy for women with VWD, the International Society on Thrombosis and Haemostasis (ISTH) conducted an international survey of health-care providers (HCP).
Results

One hundred thirty-two respondents from 39 countries were included in the final analysis. Variations in clinical practice were identified in antenatal (monitoring of plasma VWF and ferritin levels), peripartum (optimal plasma VWF target at delivery) and postpartum management (definitions used for PPH and postpartum monitoring). A key area of divergence was suitability for NA for women with type 2 and type 3 VWD, with many respondents advising against the use of NA even with VWF supplementation (29% type 2 VWD, 37% type 3 VWD) but others advising use once plasma VWF activity was >50 IU/dL (57% type 2 VWD; 50% type 3 VWD).

Conclusions

This survey highlighted areas of uncertainty surrounding common management issues for pregnant women with VWD. These data underscore the need for international collaborative research efforts focused on peripartum management to improve care for pregnant women with VWD.

Item Type: Journal Article
Murdoch Affiliation(s): Western Australian Centre for Thrombosis and Haemostasis (WACTH)
Publisher: Wiley-Blackwell
Copyright: © 2021 The Authors.
URI: http://researchrepository.murdoch.edu.au/id/eprint/63019
Item Control Page Item Control Page

Downloads

Downloads per month over past year